Cotización Humax - 028080 | ADVFN

US Dollar vs MXN

Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

Regístrate

Humax Holding (028080)

0.00

0.00

(0.00%)

Cerrado 30 Julio 1:30AM

Delayed by 15 minutes

Mejore su cartera: debates en tiempo real e ideas comerciales prácticas.

Último Precio

-

Postura de Compra

-

Postura de Venta

-

Volume Operado de la Acción

-

0.00 Rango del Día 0.00

0.00 Rango de 52 semanas 0.00

Precio Anterior

-

Precio de Apertura

-

Hora

Última hora de negociación

Volumen promedio (3 m)

-

Volumen financiero

-

Precio Promedio Ponderado

-

Form 8-K - Current report

Panbela Therapeutics Announces Third Independent Safety Review of Phase 3 ASPIRE Clinical Trial DSMB Recommended Continuation with No Trial Modification

DSMB Recommends Continuation without Modification for Third TimeSafety Review Included 395 PatientsInterim Survival Analysis Still Expected Early 2025 given Lower-Than-Expected Event Rate Low...

Panbela Announces Oral Presentation at Digestive Disease Week (DDW):

MINNEAPOLIS, June 10, 2024 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (OTCQB: PBLA), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of...

Form 8-K - Current report

Panbela Provides Business Update and Reports Q1 2024 Financial Results

MINNEAPOLIS, May 15, 2024 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (OTCQB: PBLA), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent...

Panbela Announces Issuance of New Patent in the US and Canada; Patent is for Claims of a Fixed Dose Combination of Eflornithine and Sulindac

MINNEAPOLIS, May 06, 2024 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (OTCQB: PBLA), a clinical-stage biopharmaceutical company developing disruptive therapeutics for the treatment of...

Panbela to Host First Quarter 2024 Earnings Conference Call on May 15, 2024

MINNEAPOLIS, May 01, 2024 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (OTCQB: PBLA), (“Panbela”), a clinical stage company developing disruptive therapeutics for the treatment of patients...

Acceptance of Eflornithine (DFMO) Abstract for Oral Presentation at Digestive Disease Week

MINNEAPOLIS, April 30, 2024 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (OTCQB: PBLA), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of...

Form PRER14A - Preliminary Proxy Soliciting materials

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Período †	Variación(Ptos)	Variación %	Apertura	Precio Máximo	Precio Mínimo	Avg. Vol. diario	Precio Promedio Ponderado
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

Volumen
% Mayores Alzas
% Mayores Bajas

Símbolo	Precio	Vol.

Guido2

Guido2 2 minutos hace

Think long term. The more they earn, the more capital they’ll have when this swindle ends.

GO FANNIE!
GO FREDDIE!
WELCOME END OF CHEVRON DEFERENCE!
GO ROBERT FROM YAHOO BOARD!

Princess17

Princess17 5 minutos hace

The only time you come out is when they smash it
I have a feeling you work for nefarious people

sylvia07

sylvia07 6 minutos hace

Great sign is always insider buying!

sab63090

sab63090 7 minutos hace

George, I think as you do and I read a few others who also think this might be some sort of enticement for a partnership "near term" especially should our partner take over what Missling himself has indicated (we can't do this alone)....the potential partner gets a fairly cheap entry price. Maybe I

dirkv

dirkv 14 minutos hace

Theravet (BE0974387194) Euronext Growth Paris et Bruxelles : 0.246
52w: 0.24 – 2.4
https://www.thera.vet/en/home

https://www.theravet-finances.com/images/202404_Theravet_Company_Presentation_Competition_Sport_Horses.pdf

their products:
https://bioce

dirkv

dirkv 14 minutos hace

Theravet (BE0974387194) Euronext Growth Paris et Bruxelles : 0.246
52w: 0.24 – 2.4
https://www.thera.vet/en/home

https://www.theravet-finances.com/images/202404_Theravet_Company_Presentation_Competition_Sport_Horses.pdf

their products:
https://bioce

PopsT

PopsT 15 minutos hace

I'm going to miss you guys when I'm rich. NOT

sab63090

sab63090 21 minutos hace

Seems probable to me that this is to reward a partner coming in which Missling requires (he even said so)....

rodeoup

rodeoup 23 minutos hace

I totally believe Jared will keep the mill running year around. Just take the two closest counties with close to 90,000 active and non active mining claims. I really believe Jared has all corners covered. I just flat out love this area with all its possibilities!!!

Bianca1950

Bianca1950 24 minutos hace

https://www.instagram.com/p/C-CbMhitNfE/?igsh=MXNmOGhsdXBwdjY5Yw==

236T568

236T568 28 minutos hace

Earlier tonight in front of the Caracas Presidential Palace.

https://x.com/jhonfDerecha/status/1818124222834655548

DDA

DDA 30 minutos hace

Green Maker, thanks for posting this. Q : do you think there's still something in this for us ? I'm still sitting on a pile of these shares.

palaypu0406

palaypu0406 31 minutos hace

WISHING HAPPY FRIENDSHIP DAY TO ONE AND EVERYONE!!

pcguy

pcguy 41 minutos hace

Just the same BS with this company. The same BS as the people that will claim it provides a "strong" financial position for partnering discussions. It is no wonder this company is valued where it is. The same BS claims were made the last time and guess what, none of the claims came true, only diluti

JusticeWillWin

JusticeWillWin 49 minutos hace

Read: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174832677

Split T, so COOP spends $1.5B to buy Flagstar but now, they turn around and need to raise $750M?

thanks,
ND9

JusticeWillWin

JusticeWillWin 50 minutos hace

Great MOVE by COOP

It is expected that the net proceeds of the offering will be used to repay a portion of the amounts outstanding under Mr. Cooper's MSR facilities .

Mr. Cooper Group Inc. Announces Pricing of Offering of $750 Million of Senior Notes

B

Moonlazer

Moonlazer 56 minutos hace

https://imgur.com/a/xE08x5N

I am all in the second we hit 106.29

Retest of it's last low at 106.30 was right on the retracement of the golden zone.

Double bottom just before earnings. No clearer sign to me. And I'm going to liquidate some other position

Smilin_B

Smilin_B 1 hora hace

"dissolved" and apparently the company was never sold

https://investorshub.advfn.com/uimage/uploads/2024/7/30/qajgkScreenshot_20240730_031512_Chrome.jpg

Moonlazer

Moonlazer 1 hora hace

Overnight trading has it right back at 234s. Third test of this resistance line. I'm inclined to believe we open down, but I'm not always correct on short term plays.

jake12

jake12 1 hora hace

Probably you and the goat herders using the mlns of .035 shares accumulated last fall to suppress the stock and sport your lies

vator

vator 1 hora hace

Yes ~2012 - 2013 time frame. The time frame can explain the anger of most investors as management indicated they were on the one yard line.

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones